Literature DB >> 10651897

Abnormal substance P release from the spinal cord following injury to primary sensory neurons.

M Malcangio1, M S Ramer, M G Jones, S B McMahon.   

Abstract

The neuropeptide substance P (SP) modulates nociceptive transmission within the spinal cord. Normally, SP is uniquely contained in a subpopulation of small-calibre axons (Adelta- and C-fibres) within primary afferent nerve. However, it has been shown that after nerve transection, besides being downregulated in small axons, SP is expressed de novo in large myelinated Abeta-fibres. In this study we investigated whether, following peripheral nerve injury, SP was released de novo from the spinal cord after selective activation of Abeta-fibres. Spinal cords with dorsal roots attached were isolated in vitro from rats 2 weeks following distal sciatic axotomy or proximal spinal nerve lesion (SNL). The ipsilateral dorsal roots were electrically stimulated for two consecutive periods at low- or high-threshold fibre strength, spinal cord superfusates were collected and SP content was determined by radioimmunoassay. SNL, but not axotomized or control rat cords, released significant amounts of SP after selective activation of Abeta-fibres. Not only do these data support the idea that Abeta myelinated fibres contribute to neuropathic pain by releasing SP, they also illustrate the importance of the proximity of the lesion to the cell body.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651897     DOI: 10.1046/j.1460-9568.2000.00946.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  31 in total

1.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

2.  Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Authors:  Deborah M Hegarty; Jennifer L Mitchell; Kristin C Swanson; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-04       Impact factor: 3.252

Review 3.  Ectopic discharge in Abeta afferents as a source of neuropathic pain.

Authors:  Marshall Devor
Journal:  Exp Brain Res       Date:  2009-02-26       Impact factor: 1.972

4.  Neuropathy-induced spinal GAP-43 expression is not a main player in the onset of mechanical pain hypersensitivity.

Authors:  Robby J Jaken; Sebastiaan van Gorp; Elbert A Joosten; Mario Losen; Pilar Martínez-Martínez; Marc De Baets; Marco A Marcus; Ronald Deumens
Journal:  J Neurotrauma       Date:  2011-10-20       Impact factor: 5.269

5.  Time course of substance P expression in dorsal root ganglia following complete spinal nerve transection.

Authors:  Wendy Weissner; Barbara J Winterson; Alan Stuart-Tilley; Marshall Devor; Geoffrey M Bove
Journal:  J Comp Neurol       Date:  2006-07-01       Impact factor: 3.215

Review 6.  Reappraising neuropathic pain in humans--how symptoms help disclose mechanisms.

Authors:  Andrea Truini; Luis Garcia-Larrea; Giorgio Cruccu
Journal:  Nat Rev Neurol       Date:  2013-09-10       Impact factor: 42.937

Review 7.  Mechanisms of neuropathic pain.

Authors:  James N Campbell; Richard A Meyer
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

8.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

Review 9.  Chemokines and pain mechanisms.

Authors:  Catherine Abbadie; Sonia Bhangoo; Yves De Koninck; Marzia Malcangio; Stéphane Melik-Parsadaniantz; Fletcher A White
Journal:  Brain Res Rev       Date:  2008-12-25

10.  Nitric oxide-NGF mediated PPTA/SP, ADNP, and VIP expression in the peripheral nervous system.

Authors:  Thimmasettappa Thippeswamy; Mark R Howard; Anna Siobhan Cosgrave; Daleep Kumar Arora; Jennifer S McKay; John P Quinn
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.